MMSI
Merit Medical Systems, Inc.
Healthcare · Medical Instruments & Supplies · NMS
$64.48
Data: 2026-05-28
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$3.7B
Total market value of the company
26.95
Premium valuation
14.22
Based on estimated future earnings — lower means cheaper
Rev Growth
+7.5%
Year-over-year revenue change
Profit Margin
9.0%
How much profit the company keeps from each dollar of revenue
9.1%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$85.00
+32% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 11 analysts covering this stock
About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

https://www.merit.com

Country: United States Employees: 7,500 Industry: Medical Instruments & Supplies
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% N/A
Debt must be below 33% of total assets
Cash Ratio
0.0% N/A
Interest-bearing cash below 33% of assets
Receivables
0.0% N/A
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

DISTRIBUTION
Smart money appears to be selling into strength — caution
-0.269
Returns do not compensate for the risk — negative edge
-0.0297
No positive edge detected — the data suggests staying out
-0.244
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-11.0%
Historical annualised return based on price data
-45.3%
Largest peak-to-trough decline — the worst it has been
SIDEWAYS
Price consolidating — no clear directional bias
Days in State
3
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

0.58
Less volatile than the market — more defensive
52W High
$96.74
33% below the year high
52W Low
$59.74
8% above the year low
Avg Volume
809,100
Average daily shares traded — higher means easier to buy and sell
3.4
Days it would take all short sellers to cover — higher means more crowded
Short % Float
6.5%
Moderate short interest
N/A
Annual dividend as a percentage of the share price
$2.32
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

50.50
Heavy leverage — higher financial risk if revenues decline
5.08
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
3.30
Like current ratio but excludes inventory — stricter test
Gross Margin
48.7%
Revenue left after cost of goods — higher means pricing power
Operating Margin
11.5%
Profit from core operations before interest and tax
$178M
Positive — the business generates more cash than it spends
Revenue (TTM)
$1.5B
Total revenue over the last 12 months
Net Income
$139M
Profitable — the bottom line is positive
Analyst Coverage
Analysts
11
Target High
$122.00
Target Median
$85.00
Target Low
$74.00
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.